Abstract
This is a good time to be writing this chapter. The study of human trichomonads has gone through many phases since they were first described over a century ago, and much has been achieved. The three well-established species, Trichomonas vaginalis, Trichomonas tenax, and Pentatrichomonas hominis, are defined and their nomenclature finally settled. Trichomonas vaginalis is accepted as the genuine cause of a common and sometimes serious sexually transmissible disease; reliable diagnostic methods and effective treatments are widely available. All this was true 8 years ago and yet, writing then, we stated that “it cannot really be claimed that the study of the immunology of T. vaginalis is in a particularly fruitful phase, and this may well be the cause of the recent decline in published work on the subject.”1 An enormous amount of work had been done, mainly with the aim of developing serodiagnostic tests, but there was a feeling that progress had come to a halt—and at a very frustrating point where the tests worked but not quite well enough to be clinically useful. In the last 10 years, however, the whole picture has changed, with the explosion of new immunologic and molecular biologic techniques allowing new problems to be tackled and old ones taken up again. I hope that some of the excitement now pervading the field will come through what is, inevitably, still an account based mainly on older results; but there is no doubt that in another 10 years the whole subject will have changed beyond all recognition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ackers JP, Luimden WHR: Immunology of genito-urinary trichomoniasis. Bull Mem Soc Med Hop Paris 181:190–113, 1978.
Tokura N: Biologische und immunologische Untersuchungen über die meschenparasitären Trichomonaden. Igaku Kenkyu 9:1–13, 1935.
Honigberg BM : Trichomonads. In Jackson GJ, Herman R, Singer L (eds):aImmunity to Parasitic Animals, vol 2, pp. 469–550. New York: Appleton-Century-Crofts.1970
Honigberg BM: Trichomonads of importance in human medicine. In Kreier JP (ed): Parasitic Protozoa, vol 2, pp 275–454. New York: Academic Press, 1978.
Kott H, Adler S: A serological study of Trichomonas sp. parasitic in man. Trans R Soc Trop Med Hyg 55:333–344, 1961.
Schoenherr KE: Serological investigations of trichomonads. Z Immunitaetsforsch Allerg Klin Immunol 113:83–94, 1956.
Teras JK : On the varieties of Trichomonas vaginalis. Prog Protozool, Proc 2nd Int Conf Protozool. Excerpta Med Found Int Congr Ser 91:197–198, 1965.
Teras JK: Differences in the antigenic properties within strains of Trichomonas vaginalis. Wiad Parazytol 12:357–363, 1966.
Teras JK, Jaakmees H, Nigesen U, Röigas E, Tompel H: On the agglutinogenic properties of Trichomonas vaginalis. Wiad Parazytol 12:370–377, 1966.
Mason PR: Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test. J Clin Pathol 32:1211–1215, 1979.
Street DA, Taylor-Robinson D, Ackers JP, Hanna NF, McMillan A: Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis. Br J Vener Dis 58:330–333, 1982.
Su-Lin K-E, Honigberg BM: Antigenic analysis of Trichomonas vaginalis strains by quantitative fluorescent antibody methods. Z Parasi-tenkd 69:162–181, 1983.
Honigberg BM : Comparative pathogenicity of Trichomonas vaginalis and Trichomonas galli-nae to mice. I. Gross pathology, quantitative evaluation of virulence, and some factors affecting pathogenicity. J Parasitol 47:545–571, 1961.
Su-Lin K-E, Honigberg BM: Antigenic analysis of Trichomonas vaginalis. J Protozool 23:18A, 1976.
Stepkowski S, Honigberg BM: Antigenic analysis of virulent strains of Trichomonas gallinae by gel diffusion methods. J Protozool 19:306–315, 1972.
Dwyer DM, Honigberg BM: Immunologic analysis by quantitative fluorescent antibody methods of effects of prolonged cultivation on Histomonas meleagridis (Smith). Z Parasi-tenkd 39:39–52, 1972.
Alderete JF: Antigen analysis of several pathogenic strains of Trichomonas vaginalis. Infect Immun 39:1041–1047, 1983.
Delachambre D: Etude critique comparee des antigènes de deux clones d’une même souche d’un flagellé parasite (Trichomonas vaginalis). Ann Parasitol Hum Comp 55:1–11, 1980.
Dwyer DM : Concomitant antigenic and pathogenicity changes in Histomonas meleagridis. III Int Cong Parasitol,Munich. 6:1568, Vienna, Facta 1974
Alderete JF: Identification of immunogenic and antibody-binding membrane proteins of pathogenic Trichomonas vaginalis. Infect Immun 40:284–291, 1983.
Alderete JF, Suprun-Brown L, Kasmala L, Smith J, Spence M: Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice. Infect Immun 49:463–468, 1985.
Alderete JF, Kasmala L, Metcalfe E, Garza GE: Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants. Infect Immun 53:285–293, 1986.
Alderete JF, Suprun-Brown L, Kasmala L: Monoclonal antibodies to a major surface glycoprotein immunogen differentiates isolates and subpopulations of Trichomonas vaginalis. Infect Immun 52:70–75, 1986.
Garber GE, Proctor EM, Bowie WR: Immunogenic proteins of Trichomonas vaginalis as demonstrated by the immunoblot technique. Infect Immun 51:250–253, 1986.
Torian BE, Connelly RJ, Stephens RS, Stibbs HH: Specific and common antigens of Trichomonas vaginalis detected by monoclonal antibodies. Infect Immun 43:270–275, 1984.
Connelly RJ, Torian BE, Stibbs HH: Identification of a surface antigen of Trichomonas vaginalis. Infect Immun 49:270–274, 1985.
Krieger JN, Holmes KK, Spence MR, Rein MF, McCormack WM, Tarn MR: Geographic variation among isolates of Trichomonas vaginalis: Demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique. J Infect Dis 152:979–984, 1985.
Warton A, Honigberg BM: Lectin analysis of surface saccharides in two Trichomonas vaginalis strains differing in pathogenicity. J Protozool 27:410–419, 1980.
Warton A, Honigberg BM: Analysis of surface saccharides in Trichomonas vaginalis strains with various pathogenicity levels by fluores-cein-conjugated plant lectins. Z Parasitenkd 69:149–159, 1983.
Soliman MAI, Ackers JP, Catterall RD: Isoenzyme characterization of Trichomonas vaginalis. Br J Vener Dis 58:250–256, 1982.
Chyle M, Schneiderka P, Stepan J J, Chyle P: Some enzyme and isoenzyme activities in Trichomonas vaginalis influenced by low temperature preservation and virus infection. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 20, 1985.
De Jonkheere JF : Isoenzymes and total protein patterns separated by agarose isoelectric focussing of Trichomonas vaginalis. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 21, 1985.
Teras JK, Kazakova I, Tompel H, Mirme E: On the correlation between the biochemical activity, virulence and antigenic properties of the strains of T. vaginalis. Wiad Parazytol 19:389–391, 1973.
Peterson KM, Alderete JF: Host plasma proteins on the surface of pathogenic Trichomonas vaginalis. Infect Immun 37:755–762, 1982.
Peterson KM, Alderete JF: Acquisition of α1-antitrypsin by a pathogenic strain of Trichomonas vaginalis. Infect Immun 40:640–646, 1983.
Peterson KM, Alderete JF: Selective acquisition of plasma proteins by Trichomonas vaginalis and human lipoproteins as a growth requirement for this species. Mol Biochem Parasitol 12:37–48, 1984.
Peterson KM, Alderete JF: Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J Exp Med 160:398–410, 1984.
Honigberg BM, Lindmark DC: Trichomonads and Giardia. In Soulsby EJL (ed): Immune responses in parasitic infections: Immunology, Immunopathology, and Immunoprophylaxis, vol 4, pp 99–139. Boca Raton, Fl: CRC Press, 1987.
Alderete JF, Garza GE: Soluble Trichomonas vaginalis antigens in cell-free culture superna-tants. Mol Biochem Parasitol 13:147–158, 1984.
Gillin FD, Sher A: Activation of the alternative complement pathway by Trichomonas vaginalis. Infect Immun 34:268–273, 1981.
Alderete JF, Kasmala L: Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis. Infect Immun 53:697–699, 1986.
Burgess DE: Tritrichomonas foetus: Preparation of monoclonal antibodies with effector function. Exp Parasitol 62:266–274, 1986.
Tagliabue A, Nencioni L, Villa L, Keven DF, Lowell GH, Boraschi D: Antibody dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory Ig A. Nature 306:184–186, 1983.
Landolfo S, Martinotti G, Martinotti P, Furni G: Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. J Immunol 124:508–514, 1980.
Landolfo S, Martinotti MG, Martinotti P, Furni G: Genetic control of Trichomonas vaginalis infection. I. Resistance or susceptibility among different mouse strains. Boll 1st Sieroter Milan 58:48–51, 1979.
Martinotti MG, Jemma C, Giovarelli M, Musso T: Induction of macrophage activation by immune T lymphocytes for Trichomonas vaginalis killing. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 49, 1985.
Rein MF, Sullivan JA, Mandell GL: Trichomo-nacidal activities of human polymorphonuclear neutrophils: Killing by disruption and fragmentation. J Infect Dis 142:575–585, 1980.
Holbrook TW, Boackle RJ, Vesely J, Parker BW: Trichomonas vaginalis: Alternative pathway activation of complement. Trans R Soc Trop Med Hyg 76:473–475, 1981.
Demes P, Gombosovä A: Factors of nonspecific immunity in human trichomoniasis. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 47, 1985.
Reed SL, Sargeaunt PG, Braude AI: Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg 77:248–253, 1983.
Kelly DR, Schnitzer RJ: Experimental studies on trichomoniasis. II. Immunity to reinfection in T. vaginalis infection of mice. J Immunol 69:337–342, 1952.
Schnitzer RJ, Kelly DR: Short persistence of Trichomonas vaginalis in reinfected mice. Proc Soc Exp Biol Med 82:404–406, 1953.
Kelly DR, Schumacher A, Schnitzer RJ: Experimental studies on trichomoniasis. III. Influence of the site of the immunizing infection with Trichomonas vaginalis on the immunity of mice to homologous reinfection by different routes. J Immunol 70:40–43, 1954.
Baba H : Immunological studies on trichomonads. II. On the protection of mice from trichomonas infections by the immunization with heat-killed trichomonads. Nisshin Igaku 45:16–19, 1958 (in Japanese, English summary).
Martinotti MG, Cagliani I, Lattes C, Cappucci-nelli P: Immune response and degree of protection in mice immunized with Trichomonas vaginalis antigen. G Batteriol Virol Immunol 70: 3–12, 1977.
Erlandsen SL, Meyer EA (eds): Giardia and Giardiasis. New York: Plenum Press, 1984.
Mason PM, Patterson B, Latif AS: Epidemiology and clinical diagnosis of Trichomonas vaginalis infection in Zimbabwe. Cent Afr J Med 29:53–56, 1983.
Jirovec O, Petrü M: Trichomonas vaginalis and trichomoniasis. Adv Parasitol 6:117–118, 1968.
Keighly EE: Trichomoniasis in a closed community: Efficacy of metronidazole. Br Med J 1:207–209, 1971.
Ravdin JI, Guerrant RL: A review of the parasite cellular mechanisms involved in the pathogenesis of amebiasis. Rev Infect Dis 4:1185–1207, 1982.
Krieger JN, Rein MF: Canine prostatic secretions kill Trichomonas vaginalis. Infect Immun 37:77–81, 1982.
Krieger JN, Rein MF: Zinc sensitivity of Trichomonas vaginalis: In vitro studies and clinical implications. J Infect Dis 146:341–345, 1982.
Kulda J, Budilovä M, Dohnalovä J: The effect of ferric-ammonium citrate on the virulence of Tritrichomonas foetus to the laboratory mouse. J Protozool 24:15A–16A, 1977.
Schoolnik GK, Buchanan TM, Holmes KK: Gonococci causing disseminated infection are resistant to the bactericidal action of normal human serum. J Clin Invest 58:1163, 1976.
Ackers JP : The immunology of T. vaginalis infections. Wiad Parazytol 29:41–44, 1983.
Mason PR, Forman L: In vitro attraction of polymorphonuclear leucocytes by Trichomonas vaginalis. J Parasitol 66:888–892, 1980.
Mason PR, Forman L: Polymorphonuclear cell Chemotaxis to secretions of pathogenic and nonpathogenic Trichomonas vaginalis. J Parasitol 68:457–462, 1982.
Chikunguwo S , Mason PR, Read JS: Investigation of Trichomonas vaginalis secretions and chemotactic factor. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 57, 1985.
Rasmussen SE, Rhodes JM: Chemotactic effect of Trichomonas vaginalis on polymorphonuclear leucocytes in vitro. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 50, 1985.
Brasseur P, Ballet J J, Savel J: Trichomonas vaginalis derived chemotactic activity for human polymorphonuclear leucocytes. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 51, 1985.
Gardner WA Jr, Culberson DE, Bennett BD: Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110:430–432, 1986.
Mantovani A, Polentarutti N, Peri G, Martinotti G, Landolfo F: Cytotoxicity of human peripheral blood monocytes against Trichomonas vaginalis. Clin Exp Immunol 46:391–396, 1981.
Weld JT, Kean BH: A factor in serum of human beings and animals that destroys T. vaginalis. Proc Soc Exp Biol Med 98:494–496, 1958.
Reisenhofer V: Über die Beeinflussung von Trichomonas vaginalis durch verschiedene Sera. Arch Hyg Bakteriol 146:628–635, 1963.
Samuels R, Chun-Hoon H: Serological investigation of trichomonads. I. Comparison of “natural” and immune antibodies. J Protozool 11:36–46, 1964.
Tatsuki T : Studies on Trichomonas vaginalis. II. Immunoserological reactions of Trichomonas vaginalis by sera and colostra from women infected therewith. Nagasaki Igakkai Zasshi 32:983–993, 1957. (in Japanese, English summary).
Alderete JF: Enzyme-linked immunoabsorbent assay for detecting antibody to Trichomonas vaginalis: Use of whole cells and aqueous extract as antigen. Br J Vener Dis 60:164–170, 1984.
Mathews HM, Healy GR: Evaluation of two serological tests for Trichomonas vaginalis infection. J Clin Microbiol 17:840–843, 1983.
Cogne M, Brasseur P, Ballet J J: Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis. J Clin Mi-crobiol 21:588–592, 1985.
Wos SM, Watt RM: Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis. J Clin Microbiol 24:790–795, 1986.
Chipperfield EJ, Evans BA: The influence of local infection on immunoglobulin formation in the human endocervix. Clin Exp Immunol 11:219–223, 1972.
Teras JK : On the protective effect of the blood sera of patients with trichomoniasis of the genito-urinary tract on white mice infected in-traperitoneally with cultures of Trichomonas vaginalis. Izv Akad Nauk Est SSR (Biol Ser) 10:19–26, 1961.
Ackers JP, Lumsden WHR, Catterall RD, Coyle R: Antitrichomonal antibodies in the vaginal secretions of women infected with T. vaginalis. Br J Vener Dis 51:319–323, 1975.
Su-Lin K-E: Antibody to Trichomonas vaginalis in human cervicovaginal secretions. Infect Immun 37:852–857, 1982.
Ackers JP, Catterall RD, Lumsden WHR, McMillan A: Absence of detectable local antibody in genitourinary tract secretions of male contacts of women infected with Trichomonas vaginalis. Br J Vener Dis 54:168–171, 1978.
Goldstine SN, Tsai A, Kemp CJ: Role of IgA antibody in phagocytosis by human polymorphonuclear leukocytes. In McGhee JR, Mes-tecky J (eds): The Secretory Immune System. Ann NY Acad Sei 409:824, 1983.
Yano A, Yui K, Aosai F, Kojima S, Kawana T, Ovary Z: Immune response to Trichomonas vaginalis. Immunochemical and immunobio-logical analyses of T. vaginalis antigens. Int Arch Allergy Appl Immunol 72:150–157, 1983.
Yano A, Aosai F, Yui K, Kojima S, Kawana T: Antigen-specific proliferation responses of peripheral blood lymphocytes to Trichomonas vaginalis antigen in patients with Trichomonas vaginalis. J Clin Microbiol 17:175–180, 1983.
Mason PR, Patterson BA: Proliferative response of human lymphocytes to secretory and cellular antigens of Trichomonas vaginalis. J Parasitol 71:265–268, 1985.
Adler S, Sadowsky A: Intradermal reaction in trichomonad infections. Lancet 252:867–868, 1947.
Cineder B, De Weck A (eds): Immunological Responses of the Female Reproductive Tract. WHO Workshop, Geneva, Jan 1975. Copenhagen: Scriptor, 1976.
Wakelin D: Immunity to Parasites. London: Edward Arnold, 1984.
Cappuccinelli P, Giovarelli M, Landolfo G, Martinotti LV: Depressione della riposta im-munitoria in topi infettati con Trypanosoma congolense e Trichomonas vaginalis. G Mai In-fett Parasit 27:788–791, 1975.
Martinotti G, Naresio L, Landolfo S, Giovarelli M, Cappuccinelli P: Immunodepressione de Trypanosoma congolense e Trichomonas vaginalis e crescita di tumori nel topo. Atti XVII Cong Nat Soc Ital Microbiol, 1975, pp 471–477.
Aburel E, Zervos G, Titea V, Panä S: Immunological and therapeutic investigations in vaginal trichomoniasis. Rom Med Rev 7:13–19, 1963.
SolcoTrichovac Manufacturers Product Information. Solco Basle 4127, Birsfelden-Basle, Switzerland.
Gombosova A, Demes P, Valent M: Immu-notherapeutic effect of the lactobaccillus vaccine Solco Trichovac in trichomoniasis is not mediated by cross-reacting antibodies against Trichomonas vaginalis. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 65, 1985.
Harriss JWR, Higy-Mandic L, McManus TJ: A double-blind comparative study in Trichomonas vaginalis infection: SolcoTrichovac vs. placebo. Eur J Sex Trans Dis 2:27–29, 1984.
Nevembi PM, Nyakeri LN: Clinical experience with SolcoTrichovac in the treatment of vaginal trichomoniasis. East Afr Med J 61:372–374, 1984.
Rüttgers H (ed): Trichomoniasis, Scientific Papers of the Symposium on Trichomoniasis,Basle, Oct 20, 1981. Gynäkol Rundsch 23 (suppl 2); 1–91, 1982.
Mini-symposium on SolcoTrichovac. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, pp 63–68, 1985.
Yule A, Ackers JP: Development of enzyme immunoassays for the detection of Trichomonas vaginalis antigen. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 22, 1985.
Teras J : Extraurogenital infections of man by Trichomonadidae. Abstracts Int Symp Trichomonads & Trichomoniasis, Prague, July 1985, p 83, 1985.
Alderete JF: Trichomonas vaginalis NYH286 phenotypic variation may be coordinated for a repertoire of trichomonad surface immuno-gens. Infect Immun 55:1957–1962, 1987.
Alderete JF : Alternating phenotypic expression of two classes of Trichomonas vaginalis surface markers. Rev Infect Dis 10 Suppl 2:S408–412, 1988.
Alderete JF, Demes P, Gombosova A, Valent M, Yänoska A, Fabusovä H, Kasmala L, Garza GE, Metcalf EC: Phenotypes and protein-epi-tope phenotypic variation among fresh isolates of Trichomonas vaginalis. Infect Immun 55:1037–1041, 1987.
Demes P, Gombosova A, Valent M, Jänoska A, Fabusovä H, Petrenko M: Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus. Genitourin Med 64:176–179, 1988.
Mathews HM, Moss DM, Callaway CS: Human serologic response to subcellular antigens of Trichomonas vaginalis. J Parasitol 73:601–610, 1987.
Moav N, Draghi E, David A, Gold D: Anti-Trichomonas vaginalis monoclonal antibodies including complement-dependent cytotoxicity. Immunology 63:63–69, 1988.
Torian BE, Connelly RJ, Barnes RC, Kenny GE: Antigenic heterogeneity in the 115,000 Mr major surface antigen of Trichomonas vaginalis. J Protozool 35:273–280, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Ackers, J.P. (1990). Immunologic Aspects of Human Trichomoniasis. In: Honigberg, B.M. (eds) Trichomonads Parasitic in Humans. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3224-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3224-7_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7922-8
Online ISBN: 978-1-4612-3224-7
eBook Packages: Springer Book Archive